Western drug executives long treated China as little more than a sales target. Think more than a billion potential customers, a gold mine for revenue, but nothing special in terms of fresh ideas. Lately, that thinking has changed fast. China now ranks as the world’s second-biggest pharmaceutical market. The country’s sales hit $112.8 billion in…
Why a smart approach to AI-driven drug discovery prioritizes sustainability
The fact that the biopharmaceutical industry has a large carbon footprint is well established. A 2022 study from My Green Lab confirmed that biotech and pharma are still among the globe’s top polluters. The research highlights that a mere 4% of the largest publicly-traded biotech and pharmaceutical firms have climate commitments in line with the…